Hologic Inc.

HOLX10 Dec 2024
Healthcare
$75.88
+0.01 (+0.60%)
Lowest Today
$74.44
Highest Today
$76.25
Today’s Open
$75.88
Prev. Close
$75.34
52 Week High
$84.67
52 Week Low
$68.15
To Invest in Hologic Inc.

Hologic Inc.

Healthcare
HOLX10 Dec 2024
+0.01 (+0.60%)
1M
3M
6M
1Y
5Y
Low
$74.44
Day’s Range
High
$76.24
74.44
52 Week Low
$68.15
52-Week Range
52 Week High
$84.67
68.15
1 Day
-
1 Week
-2.15%
1 month return
-4.54%
3 month return
-7.55%
6 month return
+2.46%
1 Year return
+10.27%
3 Years return
+1.4%
5 Years return
+45.18%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
11.88
BlackRock Inc
10.18
T. Rowe Price Investment Management,Inc.
9.75
Morgan Stanley - Brokerage Accounts
4.79
T. Rowe Price US Mid-Cap Growth Equity
4.63
State Street Corp
4.59
T. Rowe Price Mid-Cap Growth
4.38

Market Status

Fundamentals
Market Cap
17097.73 mln
PB Ratio
3.33
PE Ratio
22.69
Enterprise Value
17422.15 mln
Total Assets
9156 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Organisation
Hologic Inc.
Employees
6990
Industry
Medical Instruments & Supplies
CEO
Mr. Stephen P. MacMillan
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step